The U.S. Court of Appeals for the Federal Circuit (CAFC) today affirmed a Patent Trial and Appeal Board (PTAB) ruling that claims of DexCom, Inc.’s patent for implantable glucose sensors were unpatentable as obvious. The CAFC opinion was authored by Judge Nina Y. Wang of the United States District Court for the District of Colorado, sitting by designation.

Full Article Available Here